Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro models.

D Anderson1

  • 1British Industrial Biological Research Association, Carshalton, Surrey, United Kingdom.

Drug Safety
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

In vitro models offer alternatives to animal testing for toxicology screening, but validation is crucial. While some genotoxicity and skin irritation tests are accepted, others require further development for regulatory approval.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Function of hexameric RNA in packaging of bacteriophage phi 29 DNA in vitro.

Molecular cell·1998
Same author

HIV quantitation in spiked vaginocervical secretions: lack of non-specific inhibitory factors. DATRI 005 Study Team. Division of AIDS Treatment Research Initiative.

Journal of virological methods·1998
Same author

Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm.

Mutation research·1998
Same author

Evaluating hoarseness: keeping your patient's voice healthy.

American family physician·1998
Same author

Head-wag autotomography of the upper cervical spine in infantile torticollis.

Pediatric radiology·1998
Same author

An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients.

Mutation research·1998
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
Same journal

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor's Fallacy and Simpson's Paradox to Artificial Intelligence.

Drug safety·2026
See all related articles

Area of Science:

  • Toxicology
  • In vitro models
  • Biomedical research

Background:

  • Cell culture and non-cellular systems are increasingly used as alternatives to animal testing in toxicological screening.
  • The validation of in vitro screening tests against established animal studies is essential for regulatory acceptance.
  • Various in vitro systems are employed for toxicological assessments, with differing levels of validation and regulatory acceptance.

Purpose of the Study:

  • To review the current state of in vitro models for toxicological screening.
  • To discuss the validation requirements for in vitro tests, including those for irritants, carcinogens, and teratogens.
  • To present a range of in vitro tests for various organ systems and their proximity to validation.

Main Methods:

  • Review of existing literature on in vitro toxicological screening methods.

Related Experiment Videos

  • Discussion of validated and non-validated in vitro test systems.
  • Categorization of tests based on the biological system they represent (e.g., ocular, immune, hepatic).

    • Main Results:

    • Some in vitro test systems, particularly for genotoxicity and skin irritation/corrosion, have achieved validation and regulatory acceptance.
    • Other in vitro systems for various endpoints (e.g., ocular, cardiac, neurological) are in different stages of development and validation.
    • A spectrum exists from empirical tests to those closely mimicking animal models.

    Conclusions:

    • In vitro models show significant promise as alternatives to animal testing in toxicology.
    • Rigorous validation against animal studies is paramount for the widespread regulatory acceptance of new in vitro screening methods.
    • Continued development and validation are necessary to expand the utility of in vitro models across diverse toxicological endpoints.